Generic drug

department so that they will be able to come up with new and improved drugs. Due to the decline in blockbuster sales and new inventions within the pipeline, it would be wise to move into more personalized treatment such as cancer. Pfizer should not only rely on the "Cash Cow "products because the industry is a now facing a shift and the one size fits all approach is not valid anymore. Pfizer should consider acquiring smaller drug companies to strengthen its portfolio since their labs are not…

CHARITY FLORES AQUINO MBA PBE Case No. 2 POCKETING THE GREENS________________________________________ Immediate Issue or Problem: Cheap Pharma Inc. had been suffering for low sales in the past months because of competition from other generic drug brands. Mr. De Guzman and with two other Directors of Cheap Pharma Inc. propose to buy the shares of stocks of Green Med, to use the patents and develop a new product line. Negotiation was ensued and the Board Director s of Cheap Pharma ratified the…

its source a) Merck, the producer of a patented cholesterol-lowering drug b) Aliant, a provider of a telephone service c) Chiquita, a banana supplier and owner of most banana plantations Answer to Question: a. Merck like most drug companies will have a patent for their cholesterol drug. The patent is essentially the legal rights to the formula for the drug and it prevents other companies from being able to copy/ produce the same drug Merck is producing. A patent is a type of a…

don’t appreciate excessive price hikes in one of the many drugs Mylan produces. The EpiPen is designed for patients who have a severe allergic reaction to some substance or extreme cases of asthma attacks. Unfortunately for those that need the drug, prices have increased from $57 in 2007 to about $616 for a two-pack today—an increase of 1,080%. Just since 2013, price have risen from $249—that’s a 247% increase (USA Today). So why are these drug prices rising so quickly? Is there an ethical…

OrganiOrganizational Plan Quintessential Pharmaceutical’s management team consist of leaders with many years of experience in the pharmaceuticals and logistic industries. Our attitude is laser-like focused on meeting the specialty drug needs of our customer’s. Our management team consists of the President and CEO, a Chief Financial Officer and four executive vice president/directors all reporting to the CEO. Each director provides guidance and direction to their respective division with final…

pharmaceutical market, the turnover of the year ended in 31/12/2014 is about 28 billion Egyptian pounds. And being a core stone in the health care system the pharmaceutical sector must be studies considering all points of view. Simply the supply chain for drugs is presented in (figure 1). The supply chain starts from production by pharmaceutical companies to consumption by patients. 3.1.1. The producers: In this sector…

Oseltamivir is an antiviral drug used in the treatment and prophylaxis of both influenza virus A and influenza virus B. It was approved for seasonal influenza by US Food and Drug Administration in 1999, and approval from Japanese agencies and European Medicines Agency (EMA) followed soon afterwards. A pharmaceutical company Roche launched oseltamivir in the global market with Tamiflu as its brand name. In 2007 alone this pharmaceutical company was producing 400 million doses of the drug with a…

Considering the ban, it can be concluded that the reasoning is they do not want their patients to think there is any kind of outside influence on their prescribing decisions. “But the guidelines do not forbid all interactions with health care professionals. Drug representatives are permitted to provide physicians with "modest meals," but only if they are accompanied by an "informational presentation." (ProQuest, 10) It is apparent that the goal of pharmaceutical companies strictly needs to be…

Its all about who you know. Lobbyist are those who attempt to persuade legislatures. Lobbyist seek to gain support from members of congress. As stated in theatlantic.com ‘As one lobbyist told me (in 2007)’, “Twenty­-five years ago… it was ‘just keep the government out of our business, we want to do what we want to,’ and gradually that’s changed to ‘how can we make the government our partners?’ They do this by sort of selling to major corporations and trying to get them on their side. The…

insurance companies stepped in to control the growing costs of prescription drugs by buying in bulk, thus reducing individual costs, (De Wit, & Meyer, 2010). The competition is also playing a key part in reducing costs by producing similar drugs at reduced prices, (De Wit, & Meyer, 2010). At one time, a patent would keep the competition at bay, but with the production of similar drugs and patents soon expiring the generic drug companies became very…